首页 > 最新文献

European Archives of Oto-Rhino-Laryngology最新文献

英文 中文
Cochlear implantation for rare Streptococcus suis meningitis with hearing loss. 人工耳蜗植入术治疗伴有听力损失的罕见猪链球菌脑膜炎。
IF 1.9 3区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-10-01 Epub Date: 2024-05-17 DOI: 10.1007/s00405-024-08730-w
Shanshan Jiang, Xinyuan Tan, Fan Shu, Muqing Xu, Jieqing Cai, Hongzheng Zhang

Objectives: This study aimed to explore the diagnostic sensitivity of 3D heavily weighted T2-weighted MRI (T2MRI) and high-resolution computed tomography (HRCT) in patients with cochlear fibrosis associated with Streptococcus suis (S. suis) meningitis and the practicality of Cochlear implantation (CI) treatments.

Methods: Between January 2020 and December 2022, we enrolled four patients with rare cochlear S. suis meningitis with associated hearing loss despite aggressive or non-aggressive follow-up antibiotic treatment. Clinical imaging data, surgical performances and post-surgical-electrode impedance were evaluated.

Results: Combined with HRCT and T2MRI, the cochlea had varying degrees of fibrosis and ossification in different cases. However, the electrodes were successfully and wholly inserted after intraoperative removal of the ossified and fibrotic foci. Post-surgical electrode impedance values of MP1 + 2 mode were normal in all 4 cases at initial activation.

Conclusion: In patients with S. suis meningitis and associated cochlear fibrosis, T2MRI examination of the inner ear was more sensitive than HRCT. This research highlights the feasibility of CI treatment in S. suis meningitis patients with severe cochlear fibrosis.

研究目的本研究旨在探讨三维重加权T2-加权磁共振成像(T2MRI)和高分辨率计算机断层扫描(HRCT)对伴有猪链球菌(S. suis)脑膜炎的耳蜗纤维化患者的诊断敏感性以及人工耳蜗植入(CI)治疗的实用性:2020年1月至2022年12月期间,我们招募了四名罕见的耳蜗猪链球菌脑膜炎患者,他们在接受积极或非积极的后续抗生素治疗后仍伴有听力损失。我们对临床成像数据、手术表现和手术后电极阻抗进行了评估:结合 HRCT 和 T2MRI,不同病例的耳蜗有不同程度的纤维化和骨化。然而,在术中切除骨化和纤维化病灶后,电极被成功地全部插入。所有 4 个病例术后初始激活时 MP1 + 2 模式的电极阻抗值均正常:结论:对于患有猪链球菌脑膜炎并伴有耳蜗纤维化的患者,内耳的 T2MRI 检查比 HRCT 更敏感。这项研究强调了对伴有严重耳蜗纤维化的猪链球菌脑膜炎患者进行 CI 治疗的可行性。
{"title":"Cochlear implantation for rare Streptococcus suis meningitis with hearing loss.","authors":"Shanshan Jiang, Xinyuan Tan, Fan Shu, Muqing Xu, Jieqing Cai, Hongzheng Zhang","doi":"10.1007/s00405-024-08730-w","DOIUrl":"10.1007/s00405-024-08730-w","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to explore the diagnostic sensitivity of 3D heavily weighted T2-weighted MRI (T2MRI) and high-resolution computed tomography (HRCT) in patients with cochlear fibrosis associated with Streptococcus suis (S. suis) meningitis and the practicality of Cochlear implantation (CI) treatments.</p><p><strong>Methods: </strong>Between January 2020 and December 2022, we enrolled four patients with rare cochlear S. suis meningitis with associated hearing loss despite aggressive or non-aggressive follow-up antibiotic treatment. Clinical imaging data, surgical performances and post-surgical-electrode impedance were evaluated.</p><p><strong>Results: </strong>Combined with HRCT and T2MRI, the cochlea had varying degrees of fibrosis and ossification in different cases. However, the electrodes were successfully and wholly inserted after intraoperative removal of the ossified and fibrotic foci. Post-surgical electrode impedance values of MP1 + 2 mode were normal in all 4 cases at initial activation.</p><p><strong>Conclusion: </strong>In patients with S. suis meningitis and associated cochlear fibrosis, T2MRI examination of the inner ear was more sensitive than HRCT. This research highlights the feasibility of CI treatment in S. suis meningitis patients with severe cochlear fibrosis.</p>","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140956260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utilization and efficacy of platelet-rich plasma and platelet-rich fibrin in otolaryngology: a systematic evidence-based review. 富血小板血浆和富血小板纤维蛋白在耳鼻喉科中的应用和疗效:基于证据的系统性综述。
IF 1.9 3区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-10-01 Epub Date: 2024-06-24 DOI: 10.1007/s00405-024-08763-1
Alireza Sharifi, Ali Kouhi, Zara M Patel

Purpose: To explore utilization and efficacy of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in different sub-specialties of otolaryngology.

Methods: A systematic search was performed using Cochrane Central Register of Controlled Trials, PubMed, EMBASE, Medline, Clinicaltrials.gov, Scopus, and Google Scholar up to March 2024. English language randomized controlled trials with original data evaluating the use of PRP and PRF in various surgical and non-surgical procedures related to otolaryngologic sub-specialties. Dataset was limited to randomized controlled trials (RCTs) to have the best quality of evidence and possible recommendation.

Results: Our database search resulted in 591 manuscripts. Four hundred twenty-six studies were primarily excluded after reviewing the title and abstract. The remaining 165 articles were studied completely, and 51 articles met the inclusion criteria. All the studies were RCTs and dated from 2001 to 2024. They included 19 studies related to otology, 10 studies related to rhinology, 7 studies related to facial plastic surgery, 6 studies related to head and neck surgery, 3 studies related to general otolaryngology, 3 studies related to pediatrics, 2 studies related to laryngology, and 1 study related to sleep medicine.

Conclusion: PRP and PRF are safe, easy to use, and potentially effective treatment options for multiple otolaryngology pathologies. As an autologous material, there is no risk of immune reaction, and thus has been selected as a viable treatment option by many otolaryngologists. Larger studies would be helpful to confirm efficacy and allow for optimized patient selection for this treatment option.

目的:探讨富血小板血浆(PRP)和富血小板纤维蛋白(PRF)在耳鼻喉科不同亚专科中的应用和疗效:方法:使用 Cochrane Central Register of Controlled Trials、PubMed、EMBASE、Medline、Clinicaltrials.gov、Scopus 和 Google Scholar(截至 2024 年 3 月)进行系统检索。包含原始数据的英文随机对照试验,这些试验评估了 PRP 和 PRF 在与耳鼻喉亚专科相关的各种手术和非手术疗法中的应用。数据集仅限于随机对照试验(RCT),以获得最佳证据质量和可能的推荐:我们在数据库中搜索到 591 篇手稿。在审查了标题和摘要后,主要排除了 426 项研究。对剩余的 165 篇文章进行了全面研究,其中 51 篇符合纳入标准。所有研究均为 RCT,研究时间为 2001 年至 2024 年。其中包括19项与耳科相关的研究、10项与鼻科相关的研究、7项与面部整形相关的研究、6项与头颈外科相关的研究、3项与普通耳鼻喉科相关的研究、3项与儿科相关的研究、2项与喉科相关的研究以及1项与睡眠医学相关的研究:结论:PRP 和 PRF 是治疗多种耳鼻喉科病症的安全、易用且潜在有效的方法。由于是自体材料,没有免疫反应的风险,因此被许多耳鼻喉科医生选为可行的治疗方案。更大规模的研究将有助于确认疗效,并为这种治疗方法优化患者选择。
{"title":"Utilization and efficacy of platelet-rich plasma and platelet-rich fibrin in otolaryngology: a systematic evidence-based review.","authors":"Alireza Sharifi, Ali Kouhi, Zara M Patel","doi":"10.1007/s00405-024-08763-1","DOIUrl":"10.1007/s00405-024-08763-1","url":null,"abstract":"<p><strong>Purpose: </strong>To explore utilization and efficacy of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in different sub-specialties of otolaryngology.</p><p><strong>Methods: </strong>A systematic search was performed using Cochrane Central Register of Controlled Trials, PubMed, EMBASE, Medline, Clinicaltrials.gov, Scopus, and Google Scholar up to March 2024. English language randomized controlled trials with original data evaluating the use of PRP and PRF in various surgical and non-surgical procedures related to otolaryngologic sub-specialties. Dataset was limited to randomized controlled trials (RCTs) to have the best quality of evidence and possible recommendation.</p><p><strong>Results: </strong>Our database search resulted in 591 manuscripts. Four hundred twenty-six studies were primarily excluded after reviewing the title and abstract. The remaining 165 articles were studied completely, and 51 articles met the inclusion criteria. All the studies were RCTs and dated from 2001 to 2024. They included 19 studies related to otology, 10 studies related to rhinology, 7 studies related to facial plastic surgery, 6 studies related to head and neck surgery, 3 studies related to general otolaryngology, 3 studies related to pediatrics, 2 studies related to laryngology, and 1 study related to sleep medicine.</p><p><strong>Conclusion: </strong>PRP and PRF are safe, easy to use, and potentially effective treatment options for multiple otolaryngology pathologies. As an autologous material, there is no risk of immune reaction, and thus has been selected as a viable treatment option by many otolaryngologists. Larger studies would be helpful to confirm efficacy and allow for optimized patient selection for this treatment option.</p>","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141445968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severely complicated ear infection in a patient treated with ixekizumab: a case report. 一名接受ixekizumab治疗的患者严重并发耳部感染:病例报告。
IF 1.9 3区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-10-01 Epub Date: 2024-07-08 DOI: 10.1007/s00405-024-08779-7
Léonore Maertens, Naomi Pollet, Marta Clarysse, Lore Vanderbeke, Nicolas Verhaert, Christian Desloovere, Elke Loos

We report a case of a severe ear infection in a 35-year-old man treated with ixekizumab for psoriasis. Ixekizumab is a humanized monoclonal antibody that selectively prevents the interaction between interleukin 17 A and its receptor. Biologicals like ixekizumab are used to achieve symptom relief in autoimmune diseases including psoriasis. Unlike the mild upper respiratory tract infections usually described as side-effects of this treatment, we report a case of a patient who presented with a severe otitis media, complicated with a facial paresis and nasopharyngeal abscess. To the best of our knowledge, this is the first case presenting a severe, complicated ear infection as a possible side effect of ixekizumab. We conclude that when using ixekizumab, vigilance for upper airway infections is needed and if necessary, interruption of therapy should be considered. However, further research is needed to confirm this hypothesis.

我们报告了一例因银屑病而接受伊克珠单抗治疗的 35 岁男子的严重耳部感染病例。ixekizumab是一种人源化单克隆抗体,可选择性地阻止白细胞介素17A与其受体之间的相互作用。ixekizumab等生物制剂可用于缓解包括银屑病在内的自身免疫性疾病的症状。与通常描述的这种治疗方法的副作用--轻微的上呼吸道感染不同,我们报告了一例出现严重中耳炎、并发面部瘫痪和鼻咽脓肿的患者。据我们所知,这是第一例将严重、复杂的中耳炎作为ixekizumab的可能副作用的病例。我们的结论是,在使用 ixekizumab 时,需要警惕上呼吸道感染,必要时应考虑中断治疗。然而,要证实这一假设,还需要进一步的研究。
{"title":"Severely complicated ear infection in a patient treated with ixekizumab: a case report.","authors":"Léonore Maertens, Naomi Pollet, Marta Clarysse, Lore Vanderbeke, Nicolas Verhaert, Christian Desloovere, Elke Loos","doi":"10.1007/s00405-024-08779-7","DOIUrl":"10.1007/s00405-024-08779-7","url":null,"abstract":"<p><p>We report a case of a severe ear infection in a 35-year-old man treated with ixekizumab for psoriasis. Ixekizumab is a humanized monoclonal antibody that selectively prevents the interaction between interleukin 17 A and its receptor. Biologicals like ixekizumab are used to achieve symptom relief in autoimmune diseases including psoriasis. Unlike the mild upper respiratory tract infections usually described as side-effects of this treatment, we report a case of a patient who presented with a severe otitis media, complicated with a facial paresis and nasopharyngeal abscess. To the best of our knowledge, this is the first case presenting a severe, complicated ear infection as a possible side effect of ixekizumab. We conclude that when using ixekizumab, vigilance for upper airway infections is needed and if necessary, interruption of therapy should be considered. However, further research is needed to confirm this hypothesis.</p>","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141558451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nasal axis lateralization suture technique in crooked nose. 歪鼻的鼻轴侧向缝合技术。
IF 1.9 3区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-10-01 Epub Date: 2024-05-21 DOI: 10.1007/s00405-024-08740-8
Ibrahim Erdim, Beyza Akcan

Purpose: The aim of the present study was to objectively and subjectively compare the preoperative and postoperative aesthetic and functional outcomes of the correction of crooked noses using a suture technique we call "nasal axis lateralization suture (NALS)".

Method: A total of 36 patients who had preoperative and postoperative photographs taken and who completed the Rhinoplasty Outcome Evaluation (ROE) questionnaire were included in the study.

Results: Crooked noses were divided into two groups: C-shaped (17 patients) and I-shaped (19 patients). The preoperative and postoperative nasal axis angles were 145.3 ± 11.9 and 178.5 ± 3.3, respectively, in C-shaped nasal deviation. In I-shaped nasal deviation, on the other hand, the preoperative nasal axis angle was 8.8 ± 2.8, while the postoperative nasal axis angle was 1.4 ± 2.4. In terms of the ideal axis percentage before and after surgery, a significant difference was found between the C-shaped and I-shaped nasal deviation patient groups (p < 0.05). While there was a significant improvement in both groups in the evaluation based on the ROE questionnaire, satisfaction was much higher in the C-shaped nasal deviation group. In both groups, the ROE values of functional and aesthetic outcomes were significantly different compared to the preoperative values of both groups (p < 0.005).

Conclusion: NALS can be used as an alternative technique to correct both I-shaped and C-shaped nasal axis deviations.

目的:本研究旨在客观和主观地比较使用我们称之为 "鼻轴侧向缝合(NALS)"的缝合技术矫正歪鼻的术前和术后美学和功能效果:方法:共对36名患者进行了术前和术后拍照,并填写了鼻整形术效果评估(ROE)问卷:歪鼻分为两组:结果:歪鼻分为两组:C 形(17 名患者)和 I 形(19 名患者)。C 型鼻偏斜患者的术前和术后鼻轴角分别为 145.3 ± 11.9 和 178.5 ± 3.3。而 I 型鼻偏斜患者的术前鼻轴角为 8.8 ± 2.8,术后鼻轴角为 1.4 ± 2.4。就手术前后的理想轴线百分比而言,C 型鼻偏曲患者组和 I 型鼻偏曲患者组之间存在显著差异(p 结论:NALS 可作为鼻偏曲治疗的一种替代方法:NALS 可作为矫正 I 型和 C 型鼻轴线偏差的替代技术。
{"title":"Nasal axis lateralization suture technique in crooked nose.","authors":"Ibrahim Erdim, Beyza Akcan","doi":"10.1007/s00405-024-08740-8","DOIUrl":"10.1007/s00405-024-08740-8","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of the present study was to objectively and subjectively compare the preoperative and postoperative aesthetic and functional outcomes of the correction of crooked noses using a suture technique we call \"nasal axis lateralization suture (NALS)\".</p><p><strong>Method: </strong>A total of 36 patients who had preoperative and postoperative photographs taken and who completed the Rhinoplasty Outcome Evaluation (ROE) questionnaire were included in the study.</p><p><strong>Results: </strong>Crooked noses were divided into two groups: C-shaped (17 patients) and I-shaped (19 patients). The preoperative and postoperative nasal axis angles were 145.3 ± 11.9 and 178.5 ± 3.3, respectively, in C-shaped nasal deviation. In I-shaped nasal deviation, on the other hand, the preoperative nasal axis angle was 8.8 ± 2.8, while the postoperative nasal axis angle was 1.4 ± 2.4. In terms of the ideal axis percentage before and after surgery, a significant difference was found between the C-shaped and I-shaped nasal deviation patient groups (p < 0.05). While there was a significant improvement in both groups in the evaluation based on the ROE questionnaire, satisfaction was much higher in the C-shaped nasal deviation group. In both groups, the ROE values of functional and aesthetic outcomes were significantly different compared to the preoperative values of both groups (p < 0.005).</p><p><strong>Conclusion: </strong>NALS can be used as an alternative technique to correct both I-shaped and C-shaped nasal axis deviations.</p>","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141069837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharyngeal adaptation to bolus properties in patients with Parkinson's disease. 帕金森病患者咽部对栓剂特性的适应性。
IF 1.9 3区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-10-01 Epub Date: 2024-06-12 DOI: 10.1007/s00405-024-08774-y
Shakeela Saleem, Anna Miles, Jacqueline Allen

Purpose: Dysphagia is common in people with Parkinson's disease (PD). Yet, literature describing swallow function in PD using high-resolution manometry is limited. This study explored swallowing pressure metrics for varied bolus conditions in people with PD.

Method: A solid-state unidirectional catheter was used to acquire manometric data for triplicate swallows (5 ml, 10 ml, 20 ml; IDDSI 0, 2 & 4). Penetration-aspiration severity was rated during videofluoroscopy. Patient-reported measures included PDQ-8: Parkinson's Disease Questionnaire-8 and EAT-10: Eating Assessment Tool-10. Quantitative manometric swallow analysis was completed through Swallow Gateway™. Metrics were compared to published normative values and generalized linear model tests explored modulatory effects.

Results: 21 participants (76% male; mean age 69.6 years, SD 7.1) with mild-moderate severity PD were studied. Two patients (9%) aspirated for single bolus thin liquid and paste trials and 15 patients (73%) scored > 3 EAT-10. Standardized PDQ-8 scores correlated with EAT-10 (p < 0.05). Abnormality in UES relaxation and distension was demonstrated by high UES integrated relaxation pressure and low UES maximum admittance (UES MaxAdm) values across varied bolus conditions. Participants demonstrated abnormally elevated pharyngeal contractility and increased post-swallow upper-esophageal sphincter (UES) contractility for thinner liquid trials. Alterations in volume and viscosity had significant effects on the bolus timing metric-distention to contraction latency. UES peak pressure measures were altered in relation to bolus viscosity.

Conclusion: This study identifies early pharyngoesophageal contractile changes in relation to bolus volume and viscosity in PD patients, associated with subtle deterioration of self-reported swallow scores. Manometric evaluation may offer insight into PD-related swallowing changes and help optimize diagnostics and treatment planning.

目的:吞咽困难在帕金森病(PD)患者中很常见。然而,使用高分辨率测压法描述帕金森病患者吞咽功能的文献十分有限。本研究探讨了帕金森病患者在不同吞咽条件下的吞咽压力指标:方法:使用固态单向导管获取一式三份吞咽(5 毫升、10 毫升、20 毫升;IDDSI 0、2 和 4)的测压数据。在视频荧光镜检查过程中对穿透-吸入严重程度进行评分。患者报告测量包括 PDQ-8:帕金森病问卷-8 和 EAT-10:进食评估工具-10。定量人工吞咽分析通过 Swallow Gateway™ 完成。结果:21 名轻中度帕金森病患者(76% 为男性;平均年龄 69.6 岁,SD 7.1)接受了研究。两名患者(9%)吸入了单次栓剂稀薄液体和糊状试验,15 名患者(73%)的 EAT-10 评分大于 3 分。标准化 PDQ-8 评分与 EAT-10 评分相关(p 结论:该研究确定了早期咽喉疾病的诊断方法:本研究确定了与咽容量和粘度有关的早期咽喉食管收缩变化,这些变化与患者自我报告的吞咽评分的细微恶化有关。压力测量评估可帮助了解与帕金森病相关的吞咽变化,有助于优化诊断和治疗计划。
{"title":"Pharyngeal adaptation to bolus properties in patients with Parkinson's disease.","authors":"Shakeela Saleem, Anna Miles, Jacqueline Allen","doi":"10.1007/s00405-024-08774-y","DOIUrl":"10.1007/s00405-024-08774-y","url":null,"abstract":"<p><strong>Purpose: </strong>Dysphagia is common in people with Parkinson's disease (PD). Yet, literature describing swallow function in PD using high-resolution manometry is limited. This study explored swallowing pressure metrics for varied bolus conditions in people with PD.</p><p><strong>Method: </strong>A solid-state unidirectional catheter was used to acquire manometric data for triplicate swallows (5 ml, 10 ml, 20 ml; IDDSI 0, 2 & 4). Penetration-aspiration severity was rated during videofluoroscopy. Patient-reported measures included PDQ-8: Parkinson's Disease Questionnaire-8 and EAT-10: Eating Assessment Tool-10. Quantitative manometric swallow analysis was completed through Swallow Gateway™. Metrics were compared to published normative values and generalized linear model tests explored modulatory effects.</p><p><strong>Results: </strong>21 participants (76% male; mean age 69.6 years, SD 7.1) with mild-moderate severity PD were studied. Two patients (9%) aspirated for single bolus thin liquid and paste trials and 15 patients (73%) scored > 3 EAT-10. Standardized PDQ-8 scores correlated with EAT-10 (p < 0.05). Abnormality in UES relaxation and distension was demonstrated by high UES integrated relaxation pressure and low UES maximum admittance (UES MaxAdm) values across varied bolus conditions. Participants demonstrated abnormally elevated pharyngeal contractility and increased post-swallow upper-esophageal sphincter (UES) contractility for thinner liquid trials. Alterations in volume and viscosity had significant effects on the bolus timing metric-distention to contraction latency. UES peak pressure measures were altered in relation to bolus viscosity.</p><p><strong>Conclusion: </strong>This study identifies early pharyngoesophageal contractile changes in relation to bolus volume and viscosity in PD patients, associated with subtle deterioration of self-reported swallow scores. Manometric evaluation may offer insight into PD-related swallowing changes and help optimize diagnostics and treatment planning.</p>","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11416356/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141310394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proton pencil beam scanning radiotherapy in the postoperative treatment of p16 positive squamous cell tonsillar cancer - evaluation of toxicity and effectivity. 质子铅笔束扫描放疗在 p16 阳性鳞状细胞扁桃体癌术后治疗中的应用--毒性和有效性评估。
IF 1.9 3区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-10-01 Epub Date: 2024-08-28 DOI: 10.1007/s00405-024-08747-1
Jiří Kubeš, Sarah Al-Hamami, Silvia Sláviková, Pavel Vítek, Alexandra Haas, Kateřina Dědečková, Barbora Ondrová, Michal Andrlik, Matěj Navrátil, Eliška Rotnáglová, Vladimír Vondráček

Purpose: Patients with p16 positive tonsillar cancer (p16 + TC) have an excellent prognosis and long-life expectancy. Deintensification of therapy is a prevalent topic of discussion. Proton radiotherapy is one way to reduce radiation exposure and thus reduce acute and late toxicity. The aim is to evaluate treatment outcomes and toxicity of postoperative treatment with intensity-modulated proton therapy (IMPT).

Methods: Between September 2013 and November 2021, 47 patients with p16 + TC were treated postoperatively with IMPT. Median age was 54.9 (38.2-74.9) years, 31 were males and 16 were females. All patients had squamous cell carcinoma and underwent surgery as a primary treatment. Median dose of radiotherapy was 66 GyE in 33 fractions. Bilateral neck irradiation was used in 39 patients and unilateral in 8. Concomitant chemotherapy was applied in 24 patients.

Results: Median follow-up time was 4.2 (0.15-9.64) years. Five-year overall survival, relapse free survival and local control were 95.7%, 97.8% and 100%. The most common acute toxicities were dermatitis and mucositis, with grade 2 + in 61.7% and 70.2% of patients. No acute percutaneous gastrostomy insertion was necessary and intravenous rehydration was used in 12.8% of patients. The most common late toxicity was grade 1 xerostomia in 70.2% of patients and grade 2 in 10.6% of patients. Subcutaneous fibrosis of grades 2 and 3 occurred in 17.0% and 2.1% of patients, respectively. One patient developed late severe dysphagia and became PEG-dependent.

Conclusion: IMPT for the postoperative treatment of p16 + TC is feasible with excellent efficiency and acceptable acute and late toxicity.

目的:p16 阳性扁桃体癌(p16 + TC)患者预后良好,预期寿命长。减强治疗是一个普遍讨论的话题。质子放疗是减少辐射照射从而降低急性和晚期毒性的一种方法。本研究旨在评估采用调强质子疗法(IMPT)进行术后治疗的疗效和毒性:2013年9月至2021年11月期间,47名p16 + TC患者术后接受了IMPT治疗。中位年龄为54.9(38.2-74.9)岁,男性31人,女性16人。所有患者都患有鳞状细胞癌,并接受了手术作为主要治疗手段。放疗的中位剂量为66 GyE,分33次进行。39名患者接受了双侧颈部照射,8名患者接受了单侧照射。24名患者同时接受了化疗:中位随访时间为 4.2(0.15-9.64)年。五年总生存率、无复发生存率和局部控制率分别为95.7%、97.8%和100%。最常见的急性毒性反应是皮炎和粘膜炎,61.7%和70.2%的患者为2级以上。没有必要进行急性经皮胃造瘘术,12.8%的患者使用了静脉补液。最常见的晚期毒性是70.2%的患者出现1级口腔异味,10.6%的患者出现2级。分别有 17.0% 和 2.1% 的患者出现 2 级和 3 级皮下纤维化。一名患者出现晚期严重吞咽困难,需要依靠 PEG:结论:IMPT 用于 p16 + TC 术后治疗是可行的,疗效极佳,急性和晚期毒性均可接受。
{"title":"Proton pencil beam scanning radiotherapy in the postoperative treatment of p16 positive squamous cell tonsillar cancer - evaluation of toxicity and effectivity.","authors":"Jiří Kubeš, Sarah Al-Hamami, Silvia Sláviková, Pavel Vítek, Alexandra Haas, Kateřina Dědečková, Barbora Ondrová, Michal Andrlik, Matěj Navrátil, Eliška Rotnáglová, Vladimír Vondráček","doi":"10.1007/s00405-024-08747-1","DOIUrl":"10.1007/s00405-024-08747-1","url":null,"abstract":"<p><strong>Purpose: </strong>Patients with p16 positive tonsillar cancer (p16 + TC) have an excellent prognosis and long-life expectancy. Deintensification of therapy is a prevalent topic of discussion. Proton radiotherapy is one way to reduce radiation exposure and thus reduce acute and late toxicity. The aim is to evaluate treatment outcomes and toxicity of postoperative treatment with intensity-modulated proton therapy (IMPT).</p><p><strong>Methods: </strong>Between September 2013 and November 2021, 47 patients with p16 + TC were treated postoperatively with IMPT. Median age was 54.9 (38.2-74.9) years, 31 were males and 16 were females. All patients had squamous cell carcinoma and underwent surgery as a primary treatment. Median dose of radiotherapy was 66 GyE in 33 fractions. Bilateral neck irradiation was used in 39 patients and unilateral in 8. Concomitant chemotherapy was applied in 24 patients.</p><p><strong>Results: </strong>Median follow-up time was 4.2 (0.15-9.64) years. Five-year overall survival, relapse free survival and local control were 95.7%, 97.8% and 100%. The most common acute toxicities were dermatitis and mucositis, with grade 2 + in 61.7% and 70.2% of patients. No acute percutaneous gastrostomy insertion was necessary and intravenous rehydration was used in 12.8% of patients. The most common late toxicity was grade 1 xerostomia in 70.2% of patients and grade 2 in 10.6% of patients. Subcutaneous fibrosis of grades 2 and 3 occurred in 17.0% and 2.1% of patients, respectively. One patient developed late severe dysphagia and became PEG-dependent.</p><p><strong>Conclusion: </strong>IMPT for the postoperative treatment of p16 + TC is feasible with excellent efficiency and acceptable acute and late toxicity.</p>","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11416402/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142092544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of dupilumab in the treatment of CRSwNP in the real-life setting: a review of the literature. 文献综述:杜鲁单抗在现实生活中治疗 CRSwNP 的疗效和安全性。
IF 1.9 3区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-10-01 Epub Date: 2024-05-19 DOI: 10.1007/s00405-024-08725-7
Marella Reale, Giuseppe Licci, Pietro Orlando, Andrea Matucci, Franco Trabalzini, Giandomenico Maggiore, Oreste Gallo

Introduction: The recent approval of Dupilumab has profoundly revolutionized the management of patients affected by severe and recalcitrant Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). However, a review that summarizes the results of real-life studies and compares them to phase 3 studies SINUS-24 and 52 is still lacking.

Materials and methods: A search of all real-life studies published from 2019 to 2023 was performed. Patients characteristics at baseline and 6 and 12 months after starting Dupilumab were extracted and compared to those from phase 3 trials: age, sex, smoking habits, comorbid asthma and aspirin-exacerbated respiratory disease (AERD), previous endoscopic sinus surgery (ESS), hematic eosinophils and total IgE, NasalAQ2 Polyps Score (NPS), smell, SNOT-22, adverse events (AEs), and response to treatment.

Results: 15 papers were included with an overall number of 1658 patients. A higher rate of comorbidities and previous ESS was found in patients from real-life studies. In addition, they had worse smell and SNOT-22 at baseline compared to patients from SINUS-24 and 52. Comorbid and post-ESS patients tended to have a faster NPS and SNOT-22 improvement, although the absolute values were not clinically relevant. A more extensive surgery and a number of ESS ≥ 2 were related to worse olfactory outcomes, probably due to iatrogenic damage. No correlation was found between hematic eosinophils and outcomes. AEs were reported by 12.4% of patients and 2.2% had to discontinue dupilumab. Weight gain was an emergent AE (0.8%), probably related to the restored sense of smell and taste. Non-responders were 3.5% and they were switched to systemic steroid, ESS, or another biologic.

Conclusion: Despite some differences in prescription criteria between countries, dupilumab was demonstrated to be effective even in the real-life scenario. However, emerging AEs and possible unknown long-term AEs of a likely lifelong therapy should be considered.

简介最近,杜比鲁单抗(Dupilumab)获得批准,这给严重顽固性慢性鼻炎伴鼻息肉(CRSwNP)患者的治疗带来了深远的变革。然而,目前仍缺乏一篇综述,总结现实生活中的研究结果,并将其与 SINUS-24 和 52 3 期研究进行比较:对2019年至2023年发表的所有真实研究进行了检索。提取了患者基线及开始使用杜比鲁单抗后6个月和12个月的特征,并与3期试验的特征进行了比较:年龄、性别、吸烟习惯、合并哮喘和阿司匹林加重呼吸道疾病(AERD)、既往内窥镜鼻窦手术(ESS)、血液嗜酸性粒细胞和总IgE、NasalAQ2息肉评分(NPS)、气味、SNOT-22、不良事件(AEs)以及对治疗的反应:共收录了 15 篇论文,患者总数为 1658 人。结果:共收录了 15 篇论文,患者总数为 1658 人。在实际研究中发现,合并症和既往 ESS 患者的比例较高。此外,与 SINUS-24 和 52 的患者相比,这些患者的基线嗅觉和 SNOT-22 更差。合并症患者和ESS后患者的NPS和SNOT-22改善速度往往更快,但绝对值与临床无关。更大范围的手术和ESS次数≥2与嗅觉结果较差有关,这可能是由于先天性损伤造成的。嗜酸性粒细胞与疗效之间没有相关性。12.4%的患者报告了不良反应,2.2%的患者不得不停用杜匹单抗。体重增加是一种突发 AE(0.8%),可能与嗅觉和味觉的恢复有关。无应答者占3.5%,他们被转用全身类固醇、ESS或另一种生物制剂:结论:尽管各国的处方标准存在一些差异,但即使在现实生活中,dupilumab也被证明是有效的。然而,在可能的终身治疗中,应考虑新出现的AEs和可能未知的长期AEs。
{"title":"Efficacy and safety of dupilumab in the treatment of CRSwNP in the real-life setting: a review of the literature.","authors":"Marella Reale, Giuseppe Licci, Pietro Orlando, Andrea Matucci, Franco Trabalzini, Giandomenico Maggiore, Oreste Gallo","doi":"10.1007/s00405-024-08725-7","DOIUrl":"10.1007/s00405-024-08725-7","url":null,"abstract":"<p><strong>Introduction: </strong>The recent approval of Dupilumab has profoundly revolutionized the management of patients affected by severe and recalcitrant Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). However, a review that summarizes the results of real-life studies and compares them to phase 3 studies SINUS-24 and 52 is still lacking.</p><p><strong>Materials and methods: </strong>A search of all real-life studies published from 2019 to 2023 was performed. Patients characteristics at baseline and 6 and 12 months after starting Dupilumab were extracted and compared to those from phase 3 trials: age, sex, smoking habits, comorbid asthma and aspirin-exacerbated respiratory disease (AERD), previous endoscopic sinus surgery (ESS), hematic eosinophils and total IgE, NasalAQ2 Polyps Score (NPS), smell, SNOT-22, adverse events (AEs), and response to treatment.</p><p><strong>Results: </strong>15 papers were included with an overall number of 1658 patients. A higher rate of comorbidities and previous ESS was found in patients from real-life studies. In addition, they had worse smell and SNOT-22 at baseline compared to patients from SINUS-24 and 52. Comorbid and post-ESS patients tended to have a faster NPS and SNOT-22 improvement, although the absolute values were not clinically relevant. A more extensive surgery and a number of ESS ≥ 2 were related to worse olfactory outcomes, probably due to iatrogenic damage. No correlation was found between hematic eosinophils and outcomes. AEs were reported by 12.4% of patients and 2.2% had to discontinue dupilumab. Weight gain was an emergent AE (0.8%), probably related to the restored sense of smell and taste. Non-responders were 3.5% and they were switched to systemic steroid, ESS, or another biologic.</p><p><strong>Conclusion: </strong>Despite some differences in prescription criteria between countries, dupilumab was demonstrated to be effective even in the real-life scenario. However, emerging AEs and possible unknown long-term AEs of a likely lifelong therapy should be considered.</p>","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140956280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Video head impulse test in subacute and chronic stroke survivors: new perspectives for implementation of assessment in rehabilitation. 亚急性和慢性中风幸存者的视频头部冲力测试:康复评估实施的新视角。
IF 1.9 3区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-10-01 Epub Date: 2024-05-17 DOI: 10.1007/s00405-024-08721-x
Marco Tramontano, Nicola Ferri, Andrea Turolla, Amaranta Soledad Orejel Bustos, Laura Casagrande Conti, Chiara Sorge, Paolo Pillastrini, Leonardo Manzari

Introduction: The Video Head Impulse Test (vHIT) is a safe and reliable assessment of peripheral vestibular function. Many studies tested its accuracy in clinical settings for differential diagnosis and quantification of the vestibulo-oculomotor reflex (VOR) in various disorders. However, the results of its application after lesions of the CNS are discordant and have never been studied in rehabilitation. This study aims to assess the VOR performance in a sample of stroke survivors.

Methods: This is a cross-sectional study on 36 subacute and chronic stroke survivors; only persons with first-ever stroke and able to walk independently, even with supervision, were included. We performed VOR assessments for each semicircular canal by vHIT and balance assessments by the Berg Balance Scale and the MiniBESTest scale.

Results: Two hundred and sixteen semicircular canals were assessed using the Head Impulse paradigm (in both the vertical and horizontal planes), while 72 semicircular canals were assessed using the Suppressed Head Impulse paradigm (horizontal plane). There was a high prevalence of participants with dysfunctional canals, particularly for the left anterior and right posterior canals, which were each prevalent in more than one-third of our sample. Furthermore, 16 persons showed an isolated canal dysfunction. The mean VOR gain for the vertical canals had confidence intervals out of the normal values (0.74-0.91 right anterior; 0.74-0.82 right posterior; 0.73-0.87 left anterior).

Conclusion: Our findings suggest that peripheral vestibular function may be impaired in people with stroke; a systematic assessment in a rehabilitation setting could allow a more personalized and patient-centred approach.

简介视频头脉冲测试(vHIT)是一种安全可靠的外周前庭功能评估方法。许多研究测试了其在临床环境中的准确性,用于鉴别诊断和量化各种疾病的前庭-运动反射(VOR)。然而,中枢神经系统病变后的应用结果并不一致,也从未在康复领域进行过研究。本研究旨在评估中风幸存者样本的 VOR 表现:本研究是一项横断面研究,对象是 36 名亚急性和慢性中风幸存者,其中仅包括首次中风且能够独立行走(即使在有人看护的情况下)的患者。我们通过 vHIT 对每个半规管进行了 VOR 评估,并通过 Berg 平衡量表和 MiniBESTest 量表进行了平衡评估:使用头部冲量范式(垂直和水平面)评估了 216 个半规管,使用抑制头部冲量范式(水平面)评估了 72 个半规管。受试者中出现耳道功能障碍的比例很高,尤其是左前和右后耳道,在我们的样本中有三分之一以上的受试者出现了这两种情况。此外,有 16 人出现了孤立的耳道功能障碍。垂直管道的平均 VOR 增益的置信区间超出正常值(0.74-0.91 右前;0.74-0.82 右后;0.73-0.87 左前):我们的研究结果表明,脑卒中患者的外周前庭功能可能会受损;在康复环境中进行系统评估可使治疗方法更加个性化,并以患者为中心。
{"title":"Video head impulse test in subacute and chronic stroke survivors: new perspectives for implementation of assessment in rehabilitation.","authors":"Marco Tramontano, Nicola Ferri, Andrea Turolla, Amaranta Soledad Orejel Bustos, Laura Casagrande Conti, Chiara Sorge, Paolo Pillastrini, Leonardo Manzari","doi":"10.1007/s00405-024-08721-x","DOIUrl":"10.1007/s00405-024-08721-x","url":null,"abstract":"<p><strong>Introduction: </strong>The Video Head Impulse Test (vHIT) is a safe and reliable assessment of peripheral vestibular function. Many studies tested its accuracy in clinical settings for differential diagnosis and quantification of the vestibulo-oculomotor reflex (VOR) in various disorders. However, the results of its application after lesions of the CNS are discordant and have never been studied in rehabilitation. This study aims to assess the VOR performance in a sample of stroke survivors.</p><p><strong>Methods: </strong>This is a cross-sectional study on 36 subacute and chronic stroke survivors; only persons with first-ever stroke and able to walk independently, even with supervision, were included. We performed VOR assessments for each semicircular canal by vHIT and balance assessments by the Berg Balance Scale and the MiniBESTest scale.</p><p><strong>Results: </strong>Two hundred and sixteen semicircular canals were assessed using the Head Impulse paradigm (in both the vertical and horizontal planes), while 72 semicircular canals were assessed using the Suppressed Head Impulse paradigm (horizontal plane). There was a high prevalence of participants with dysfunctional canals, particularly for the left anterior and right posterior canals, which were each prevalent in more than one-third of our sample. Furthermore, 16 persons showed an isolated canal dysfunction. The mean VOR gain for the vertical canals had confidence intervals out of the normal values (0.74-0.91 right anterior; 0.74-0.82 right posterior; 0.73-0.87 left anterior).</p><p><strong>Conclusion: </strong>Our findings suggest that peripheral vestibular function may be impaired in people with stroke; a systematic assessment in a rehabilitation setting could allow a more personalized and patient-centred approach.</p>","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140956429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the usefulness of tubomanometry as a diagnostic tool in Eustachian tube dysfunction. 评估测管法作为咽鼓管功能障碍诊断工具的实用性。
IF 1.9 3区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-10-01 Epub Date: 2024-05-29 DOI: 10.1007/s00405-024-08724-8
Mayte Herrera, Estefanía Miranda, Ithzel Villarreal, Teresa Crespo, Guillermo Plaza

Purpose: This study aims to evaluate the validity and reliability of tubomanometry (TMM) in diagnosing obstructive Eustachian tube dysfunction (OETD) before balloon Eustachian tuboplasty (BET).

Methods: A prospective cohort study was conducted, involving 25 patients with sinonasal pathology, 75 patients with middle ear disease, and 25 healthy subjects, totaling 250 ears. All participants underwent comprehensive physical examinations, including TMM, nasal videoendoscopy, otoendoscopy, Valsalva maneuver (VM), tympanometry, and audiometry. Additionally, various scales such as ETDQ-7 and ETS-7 were employed. Tympanometry served as the gold standard for assessing OETD, and comparisons were made among the measures across the three groups.

Results: Among the 125 participants, 44.8% (n = 56) were female, and 55.2% (n = 69) were male, with ages ranging from 19 to 93 years (M = 48.5; SD = 15.6). In our study, VM demonstrated high sensitivity (86.3%) when tympanometry was considered the gold standard. Conversely, TMM, ETDQ-7, and ETS-7 exhibited high specificity, with ETDQ-7 showing the highest specificity (87.4%). Regarding TMM, all R values in patients within the middle ear disease group were pathological (R > 1).

Conclusion: TMM has exhibited notable specificity as a diagnostic tool compared to tympanogram and VM. Nonetheless, the combination of TMM and ETDQ-7 has enabled us to conduct a diagnostic assessment with high sensitivity and specificity for chronic OETD diagnosis.

目的:本研究旨在评估咽鼓管球囊成形术(BET)前使用咽鼓管测量法(TMM)诊断阻塞性咽鼓管功能障碍(OETD)的有效性和可靠性:我们进行了一项前瞻性队列研究,其中包括 25 名鼻窦病变患者、75 名中耳疾病患者和 25 名健康受试者,共计 250 耳。所有参与者都接受了全面的身体检查,包括TMM、鼻腔视频内窥镜检查、耳内窥镜检查、瓦尔萨尔瓦手法(VM)、鼓室测量和听力测量。此外,还采用了各种量表,如 ETDQ-7 和 ETS-7。鼓室测听是评估耳聋的金标准,并对三组的测量结果进行了比较:在 125 名参与者中,44.8%(n = 56)为女性,55.2%(n = 69)为男性,年龄从 19 岁到 93 岁(M = 48.5;SD = 15.6)不等。在我们的研究中,当鼓室测压法被视为金标准时,VM 表现出很高的灵敏度(86.3%)。相反,TMM、ETDQ-7 和 ETS-7 则表现出较高的特异性,其中 ETDQ-7 的特异性最高(87.4%)。关于 TMM,中耳疾病组患者的所有 R 值均为病理值(R > 1):结论:与鼓室造影和VM相比,TMM作为诊断工具具有显著的特异性。尽管如此,TMM 和 ETDQ-7 的结合使我们能够对慢性中耳炎的诊断进行高敏感性和高特异性的诊断评估。
{"title":"Assessing the usefulness of tubomanometry as a diagnostic tool in Eustachian tube dysfunction.","authors":"Mayte Herrera, Estefanía Miranda, Ithzel Villarreal, Teresa Crespo, Guillermo Plaza","doi":"10.1007/s00405-024-08724-8","DOIUrl":"10.1007/s00405-024-08724-8","url":null,"abstract":"<p><strong>Purpose: </strong>This study aims to evaluate the validity and reliability of tubomanometry (TMM) in diagnosing obstructive Eustachian tube dysfunction (OETD) before balloon Eustachian tuboplasty (BET).</p><p><strong>Methods: </strong>A prospective cohort study was conducted, involving 25 patients with sinonasal pathology, 75 patients with middle ear disease, and 25 healthy subjects, totaling 250 ears. All participants underwent comprehensive physical examinations, including TMM, nasal videoendoscopy, otoendoscopy, Valsalva maneuver (VM), tympanometry, and audiometry. Additionally, various scales such as ETDQ-7 and ETS-7 were employed. Tympanometry served as the gold standard for assessing OETD, and comparisons were made among the measures across the three groups.</p><p><strong>Results: </strong>Among the 125 participants, 44.8% (n = 56) were female, and 55.2% (n = 69) were male, with ages ranging from 19 to 93 years (M = 48.5; SD = 15.6). In our study, VM demonstrated high sensitivity (86.3%) when tympanometry was considered the gold standard. Conversely, TMM, ETDQ-7, and ETS-7 exhibited high specificity, with ETDQ-7 showing the highest specificity (87.4%). Regarding TMM, all R values in patients within the middle ear disease group were pathological (R > 1).</p><p><strong>Conclusion: </strong>TMM has exhibited notable specificity as a diagnostic tool compared to tympanogram and VM. Nonetheless, the combination of TMM and ETDQ-7 has enabled us to conduct a diagnostic assessment with high sensitivity and specificity for chronic OETD diagnosis.</p>","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141160847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prophylactic antibiotics in sialendoscopy: a randomized clinical trial. 鞘内镜检查中的预防性抗生素:随机临床试验。
IF 1.9 3区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-10-01 Epub Date: 2024-07-13 DOI: 10.1007/s00405-024-08773-z
Carlos M Chiesa-Estomba, Alvaro Sanchez-Barrueco, Giovanni Cammaroto, Jerome R Lechien, Miguel Mayo-Yanez, Carlos Cenjor, Pasquale Capaccio, Carlos Saga-Gutierrez

Objective: Antibiotics have been prescribed routinely in sialendoscopy procedures to reduce the risk of postoperative infection, despite the limited evidence supporting this practice. Being necessary to assess the need for antibiotics in Sialendoscopy, aiming to provide evidence-based guidance to clinicians regarding antibiotic administration in this procedure.

Materials & method: A prospective, randomized, double-blind, controlled clinical trial to evaluate the of prophylactic antibiotics in Sialendoscopy was designed.

Results: A total of 80 patients were included in this study, including 57 females (71.8%) and 23 males (28.8%). In terms of prophylaxis, 36 patients (45%) received prophylactic treatment, and 44 patients (55%) did not. The occurrence of infectious events was observed in 2 patients (5.6%) with prophylaxis and 4 patients (9.1%) without prophylaxis. However, this difference was not statistically significant (p = 0.556).

Conclusion: In conclusion, our prospective, randomized clinical trial aimed to address the debate regarding the use of prophylactic antibiotics in sialendoscopy. Our study's findings suggest that the routine use antibiotics may not be necessary to prevent postoperative infections in sialendoscopy procedures. These results have important implications for clinical practice, potentially reducing the unnecessary use of antibiotics and addressing concerns related to antibiotic resistance and adverse drug reactions.

目的:尽管支持这种做法的证据有限,但在虹膜内窥镜手术中常规使用抗生素以降低术后感染的风险。因此,有必要评估咽内镜手术中使用抗生素的必要性,旨在为临床医生在该手术中使用抗生素提供循证指导:设计了一项前瞻性、随机、双盲、对照临床试验,以评估在虹膜内窥镜检查中预防性使用抗生素的情况:本研究共纳入 80 名患者,包括 57 名女性(71.8%)和 23 名男性(28.8%)。在预防性治疗方面,36 名患者(45%)接受了预防性治疗,44 名患者(55%)未接受预防性治疗。有 2 名患者(5.6%)接受了预防性治疗,4 名患者(9.1%)没有接受预防性治疗。然而,这一差异并无统计学意义(P = 0.556):总之,我们的前瞻性随机临床试验旨在解决有关在鞘内镜检查中使用预防性抗生素的争论。我们的研究结果表明,常规使用抗生素可能并不是预防腕内镜手术术后感染所必需的。这些结果对临床实践具有重要意义,有可能减少不必要的抗生素使用,并解决与抗生素耐药性和药物不良反应相关的问题。
{"title":"Prophylactic antibiotics in sialendoscopy: a randomized clinical trial.","authors":"Carlos M Chiesa-Estomba, Alvaro Sanchez-Barrueco, Giovanni Cammaroto, Jerome R Lechien, Miguel Mayo-Yanez, Carlos Cenjor, Pasquale Capaccio, Carlos Saga-Gutierrez","doi":"10.1007/s00405-024-08773-z","DOIUrl":"10.1007/s00405-024-08773-z","url":null,"abstract":"<p><strong>Objective: </strong>Antibiotics have been prescribed routinely in sialendoscopy procedures to reduce the risk of postoperative infection, despite the limited evidence supporting this practice. Being necessary to assess the need for antibiotics in Sialendoscopy, aiming to provide evidence-based guidance to clinicians regarding antibiotic administration in this procedure.</p><p><strong>Materials & method: </strong>A prospective, randomized, double-blind, controlled clinical trial to evaluate the of prophylactic antibiotics in Sialendoscopy was designed.</p><p><strong>Results: </strong>A total of 80 patients were included in this study, including 57 females (71.8%) and 23 males (28.8%). In terms of prophylaxis, 36 patients (45%) received prophylactic treatment, and 44 patients (55%) did not. The occurrence of infectious events was observed in 2 patients (5.6%) with prophylaxis and 4 patients (9.1%) without prophylaxis. However, this difference was not statistically significant (p = 0.556).</p><p><strong>Conclusion: </strong>In conclusion, our prospective, randomized clinical trial aimed to address the debate regarding the use of prophylactic antibiotics in sialendoscopy. Our study's findings suggest that the routine use antibiotics may not be necessary to prevent postoperative infections in sialendoscopy procedures. These results have important implications for clinical practice, potentially reducing the unnecessary use of antibiotics and addressing concerns related to antibiotic resistance and adverse drug reactions.</p>","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141603470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Archives of Oto-Rhino-Laryngology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1